A kind of preparation method of high-purity thalidomide alpha crystal form

A technology of thalidomide and its crystal form, which is applied in the field of preparation of high-purity thalidomide α crystal form, and can solve the problems of difficult reuse of mother liquor, high social and economic costs, etc.

Active Publication Date: 2021-09-17
CINKATE PHARMA INTERMEDIATES +1
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The above methods all need to use polar solvents with high boiling points, as well as solvents such as ketones and alcohols. The mother liquor after crystallization is very difficult to reuse, and the social and economic costs are relatively high.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of preparation method of high-purity thalidomide alpha crystal form
  • A kind of preparation method of high-purity thalidomide alpha crystal form
  • A kind of preparation method of high-purity thalidomide alpha crystal form

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0085] Add 50 g of crude thalidomide and 1,500 g of tetrahydrofuran into a 2L three-neck round bottom flask, stir mechanically, heat the oil bath to reflux, add 150 g of purified water, and dissolve all the solids. Keep the oil bath temperature at 95-100 ° C, and distill at atmospheric pressure Tetrahydrofuran, after recovery of tetrahydrofuran, the mother liquor was cooled to room temperature, vacuum-filtered under reduced pressure, and the filter cake was vacuum-dried at 80°C for 4 hours to obtain 48.5 g of thalidomide crystals, with a recrystallization yield of 97.0% and a purity of 99.8%. The residual amount was almost 0%. DSC test results such as figure 1 As shown, the endothermic peaks detected by DSC are 271.55° C. (the characteristic endothermic peak of the α crystal form) and 274.17° C., indicating that the obtained thalidomide crystals are of the α crystal form and have high purity. X-ray diffraction pattern (XRPD) as Figure 2A As shown, the X-ray diffraction data...

Embodiment 2

[0087] Add 50 g of crude thalidomide and 150 g of tetrahydrofuran into a 500 ml three-necked round-bottomed flask successively, stir mechanically, heat the oil bath to reflux, add 50 g of purified water, and dissolve all the solids, lower the temperature to room temperature and concentrate under reduced pressure to recover tetrahydrofuran, and the recovery of tetrahydrofuran is complete , the mother liquor was suction-filtered, and the filter cake was vacuum-dried at 80° C. for 4 hours to obtain 49.0 g of thalidomide crystal product, the recrystallization yield was 98.0%, the purity was 99.7%, and the residual tetrahydrofuran was almost 0%. DSC test results such as image 3 As shown, the endothermic peaks detected by DSC are 271.47°C and 274.32°C, indicating that the obtained thalidomide crystals are in the α crystal form and have high purity. X-ray diffraction pattern (XRPD) as Figure 4A As shown, the X-ray diffraction data as Figure 4B shown. It also shows that the obta...

Embodiment 3

[0089] Thalidomide crude product 50g, tetrahydrofuran recovered in Example 1 was weighed 1500g and added to a 2L three-necked round-bottomed flask successively, mechanically stirred, the oil bath was heated to reflux, 150g of purified water was added, all the solids were dissolved, and the mixture was reduced to Concentrate under reduced pressure at room temperature to recover tetrahydrofuran. After the recovery of tetrahydrofuran is complete, the mother liquor is suction-filtered, and the filter cake is vacuum-dried at 80°C for 4 hours to obtain 48.8 g of thalidomide crystals. The recrystallization yield is 97.6%, the purity is 99.8%, and tetrahydrofuran remains amount is almost 0%. DSC test results such as Figure 5 As shown, the endothermic peaks detected by DSC are 271.31°C (the characteristic endothermic peak of the α crystal form) and 274.23°C, indicating that thalidomide is in the α crystal form and has high purity. X-ray diffraction pattern (XRPD) as Figure 6A As sh...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a preparation method of high-purity thalidomide α crystal form. Specifically, the high-purity α crystal form thalidomide prepared by the method of the present invention. And the organic solvent used in the method of the present invention can be recycled and reused by simple distillation, the crystallization yield is over 95%, the operation is simple, the environment is green and friendly, and it has high economic and social value. The process used in the method of the present invention is easy to realize large-scale industrial production.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a preparation method of high-purity α-crystal form of thalidomide. Background technique [0002] Thalidomide (Distaval) is a synthetic glutamic acid derivative, alias: thalidomide, reaction stop, thalidomide, thalidomide, thalidomide, thalidomide Ketones, whose structural formula is as follows: [0003] [0004] The document J.CHEM.SOC.PERKIN TRANS.2 1994 (2063-2067) studied the crystal form of thalidomide, and found that there are two crystal forms of thalidomide, namely α crystal form and β crystal form, Differential scanning calorimetry (DSC) was used to detect that the α crystal form had an endothermic peak at 271.5-273.0°C, and the β crystal form only had an endothermic peak at 275.0-276.5°C. It is believed that the α crystal form will have an endothermic peak during the DSC detection process. Part or all of it is transformed into the β crystal form, so tha...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07D401/04
CPCC07B2200/13C07D401/04
Inventor 文勇王果仇波肖飞
Owner CINKATE PHARMA INTERMEDIATES
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products